RA Capital Management
3 portfolio companies · $67.1M tracked · Biotechnology, Pharmaceuticals
Investors searching for companies backed by RA Capital Management can find key details on recent deals tracked by StreetZero. The firm has participated in 3 deals totaling $67.1M, focused on Pharmaceuticals and Biotechnology sectors. This information helps identify active investments in the life sciences space.
The RA Capital Management portfolio includes companies such as Typewriter Therapeutics, Inc., Navigator Medicines, Inc., and Dignify Therapeutics, LLC. These recent additions highlight the firm's strategy in backing innovative biotech and pharma ventures. Users can explore these portfolio companies to understand RA Capital Management's current investment focus.